Evidence map›Paper›PMID 33404148›Full record

ArticleDermatologic therapy2021

Fluorescence of nails and hair on Wood's lamp examination in Covid pandemic; undefined effect of Favipiravir in humans.

Melek Aslan Kayıran, Filiz Cebeci, Vefa Aslı Erdemir, Hasan Aksoy, Necmettin Akdeniz, Mehmet Salih Gürel

Open access · greenAbstract readLetter
In one paragraph

Article in Dermatologic therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Optical biometric measurements in patients with previous COVID-19 treatment.Spektrum der Augenheilkunde : Zeitschrift der Osterreichischen Ophthalmologischen Gesellschaft, OOG · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Melek Aslan KayıranDepartment of Dermatology, İstanbul Medeniyet University, Göztepe Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0003-4347-3134
Filiz CebeciDepartment of Dermatology, İstanbul Medeniyet University, Göztepe Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0002-9109-3892
Vefa Aslı ErdemirDepartment of Dermatology, İstanbul Medeniyet University, Göztepe Training and Research Hospital, İstanbul, Turkey.
Hasan AksoyDepartment of Dermatology, İstanbul Medeniyet University, Göztepe Training and Research Hospital, İstanbul, Turkey.ORCID 0000-0002-5207-9633
Necmettin AkdenizDepartment of Dermatology, İstanbul Medeniyet University, Göztepe Training and Research Hospital, İstanbul, Turkey.
Mehmet Salih GürelDepartment of Dermatology, İstanbul Medeniyet University, Göztepe Training and Research Hospital, İstanbul, Turkey.
Istanbul Medeniyet University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19NailsAmidesFluorescenceHumansPandemicsPyrazinesSARS-CoV-2Ultraviolet RaysAmidesfavipiravirPyrazines

Identifiers

PMID33404148
PMCPMC7883070
OpenAlexW3119861098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.